All In Biotech

Free tool

FAERS Monitor: Vyscoxa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211759 or its brand name (Vyscoxa, Celecoxib). Reports on generic versions are filed under their own applications.

Reports

35,685

Serious

26,846

75% of reports

Hospitalization

14,064

Death reported

6,053

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5,458
  • off label use3,498
  • fatigue3,409
  • arthralgia3,339
  • pain3,325
  • nausea3,299
  • diarrhoea2,965
  • vomiting2,687
  • rheumatoid arthritis2,594
  • rash2,565
  • headache2,487
  • condition aggravated2,434
  • dizziness2,417
  • malaise2,231
  • dyspnoea2,192

Reports by year received

View as table
YearReports
2004857
2005679
2006215
2007349
2008556
2009465
2010444
2011658
2012544
2013465
2014450
20151,302
20161,642
20171,740
20181,918
20192,365
20202,679
20212,689
20223,027
20232,739
20243,358
20254,089
20262,455

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,018,474 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal2,59413.813.330,139
arthralgiaSignal3,3394.84.610,043
condition aggravatedSignal2,4344.74.67,246
rashSignal2,5653.53.44,606
vomitingSignal2,6873.43.34,582
painSignal3,3253.23.15,157
malaiseSignal2,2313.02.93,037
dizzinessSignal2,4172.92.82,990
diarrhoeaSignal2,9652.72.63,297
fatigueSignal3,4092.62.53,432
nauseaSignal3,2992.52.42,965
drug ineffectiveSignal5,4582.42.44,960
off label useSignal3,4982.42.32,848
headacheSignal2,4872.32.31,965
dyspnoeaSignal2,1922.32.21,624

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.